ARG59831

anti-TRAFD1 antibody

anti-TRAFD1 antibody for Western blot and Human

Overview

Product Description Rabbit Polyclonal antibody recognizes TRAFD1
Tested Reactivity Hu
Tested Application WB
Host Rabbit
Clonality Polyclonal
Isotype IgG
Target Name TRAFD1
Antigen Species Human
Immunogen Recombinant fusion protein corresponding to aa. 1-260 of Human TRAFD1 (NP_006691.1).
Conjugation Un-conjugated
Alternate Names TRAF-type zinc finger domain-containing protein 1; FLN29; Protein FLN29

Application Instructions

Application Suggestion
Tested Application Dilution
WB1:500 - 1:1000
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.
Positive Control A-375
Observed Size 78 kDa

Properties

Form Liquid
Purification Affinity purified.
Buffer PBS (pH 7.3), 0.02% Sodium azide and 50% Glycerol.
Preservative 0.02% Sodium azide
Stabilizer 50% Glycerol
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 10906 Human TRAFD1

Swiss-port # O14545 Human TRAF-type zinc finger domain-containing protein 1

Gene Symbol TRAFD1
Gene Full Name TRAF-type zinc finger domain containing 1
Background The innate immune system confers host defense against viral and microbial infection, and TRAFD1 is a negative feedback regulator that controls excessive immune responses (Sanada et al., 2008 [PubMed 18849341]).[supplied by OMIM, Dec 2009]
Function Negative feedback regulator that controls excessive innate immune responses. Regulates both Toll-like receptor 4 (TLR4) and DDX58/RIG1-like helicases (RLH) pathways. May inhibit the LTR pathway by direct interaction with TRAF6 and attenuation of NF-kappa-B activation. May negatively regulate the RLH pathway downstream from MAVS and upstream of NF-kappa-B and IRF3 (By similarity). [UniProt]
Calculated MW 65 kDa